Woodline Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9M | Sell |
|
|||||
|
2025
Q1 | $67.4M | Buy |
|
|||||
|
2024
Q4 | $73.6M | Buy |
|
|||||
|
2024
Q3 | $105M | Sell |
|
|||||
|
2024
Q2 | $191M | Buy |
|
|||||
|
2024
Q1 | $164M | Buy |
|
|||||
|
2023
Q4 | $149M | Buy |
|
|||||
|
2023
Q3 | $112M | Buy |
|
|||||
|
2023
Q2 | $34.2M | Sell |
|
|||||
|
2023
Q1 | $127M | Sell |
|
|||||
|
2022
Q4 | $115M | Sell |
|
|||||
|
2022
Q3 | $129M | Buy |
|
|||||
|
2022
Q2 | $31.2M | Sell |
|
|||||
|
2022
Q1 | $73.7M | Buy |
|
|||||
|
2021
Q4 | $57M | Buy |
|
|||||
|
2021
Q3 | $45.9M | Sell |
|
|||||
|
2021
Q2 | $43.5M | Sell |
|
|||||
|
2021
Q1 | $88M | Buy |
|
|||||
|
2020
Q4 | $9.76M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $19.2M | Buy |
|
|||||
|
2020
Q1 | $13.4M | Buy |
|